Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in IgA Nephropathy
NCT02351752Phase 4Completed
- Start
- Jan 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hydroxychloroquine in IgA nephropathy (IgAN). Primary endpoint: Proteinuria at 4 months. Started Jan 2015; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02351752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351752.